Computational Chemistry & Molecular Analysis for Autoimmune Diseases

Research into computational chemistry & molecular analysis approaches for Autoimmune Diseases. AI-powered analysis of mechanisms, evidence, and clinical status.

About Computational Chemistry & Molecular Analysis

Structured molecular intelligence — drug-likeness assessment via Lipinski's Rule of Five, blood-brain barrier penetration prediction, binding affinity interpretation from IC50/Ki data, target overlap analysis, and synergy scoring using PubChem, ChEMBL, and Open Targets data.

About Autoimmune Diseases

New autoimmune treatments in 2026: JAK inhibitors, precision immunotherapy, microbiome approaches. AI-analyzed across MS, lupus, RA, and Crohn's.

Standard of Care: Immunosuppressants (methotrexate, azathioprine), biologics (TNF inhibitors, IL-6 blockers, B-cell depleters), JAK inhibitors — primarily symptom control and flare prevention.